CYP2E1 polymorphisms and gene––environment interactions in the risk of upper aerodigestive tract cancers among Indians

By Soya S S   Vinod T   Reddy K S   Gopalakrishnan S   Adithan C  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 551-560

Future Medicine

Access to resources Recommend Favorite

Intravesical Drug Delivery into the Bladder to Treat Cancers

By  

Current Drug Delivery, Vol. 6, Iss. 3, 2009-07 ,pp. : 227-237

Bentham Science Publishers

Access to resources Recommend Favorite

Intravesical therapy for bladder cancer

By Williams Steve K   Hoenig David M   Ghavamian Reza   Soloway Mark  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 947-958

Informa Healthcare

Access to resources Recommend Favorite

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy

By Ramanathan Ramesh  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1591-1596

Springer Publishing Company

Access to resources Recommend Favorite

Atorvastatin as standard therapy on the CARDS

By  

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite